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Migraine is one of the ten most disabling disorders worldwide,
and despite recent developments in the management of mi-
graine, it remains underdiagnosed and undertreated. The man-
agement of migraine includes diagnosis, preventive measures
and treatment of migraine attacks.
Migraine diagnosis. Migraine is a chronic condition with re-
current attacks. Most (but not all) migraine attacks are associ-
ated with headaches. Migraine headaches usually are described
as an intense, throbbing or pounding pain that involves one
temple. (Sometimes the pain is located in the forehead, around
the eye, or at the back of the head). The pain usually is unilat-
eral (on one side of the head), although about a third of the
time the pain is bilateral (on both sides of the head). The uni-
lateral headaches typically change sides from one attack to the
next. (In fact, unilateral headaches that always occur on the
same side should alert the doctor to consider a secondary
headache, for example, one caused by a brain tumor). A mi-
graine headache usually is aggravated by daily activities such as
walking upstairs. Nausea, vomiting, diarrhea, facial pallor, cold
hands, cold feet, and sensitivity to light and sound commonly
accompany migraine headaches. As a result of this sensitivity
to light and sound, migraine sufferers usually prefer to lie in a
quiet, dark room during an attack. A typical attack lasts be-
tween 4 and 72 hours. An estimated 20% of migraine
headaches are associated with an aura. Usually, the aura pre-
cedes the headache, although occasionally it may occur simul-
taneously with the headache.
Migraine treatment. Treatment of migraine includes therapies
that may or may not involve medications. Therapy that does
not involve medications can provide symptomatic and preven-
tative therapy. Using ice, biofeedback, and relaxation techniques
may be helpful in stopping an attack once it has started. Sleep
may be the best medicine if it is possible. Preventing migraine
takes motivation for the patient to make some life changes. Pa-
tients are educated as to triggering factors that can be avoided.
These triggers include: smoking, and avoiding certain foods es-
pecially those high in tyramine such as sharp cheeses or those
containing sulphites (wines) or nitrates (nuts, pressed meats).
Generally, leading a healthy life-style with good nutrition, an
adequate intake of fluids, sufficient sleep and exercise may be
useful. 
Medication for migraine. Individuals with occasional mild mi-
graine headaches that do not interfere with daily activities usu-
ally medicate themselves with over-the-counter (OTC or
non-prescription) pain relievers (analgesics). Many OTC anal-
gesics are available. OTC analgesics have been shown to be safe
and effective for short-term relief of headache. It is important
to use an sufficient dose of analgetic on NSAIDs when treating
migraine (Aspirin 1000 mg or Ibuprofen 400 – 800 mg or Di-
clofenac 50 – 100 mg or Ketoprofen 100 mg or Naproxen 500-
1000 mg). When abovementioned medications are contra -
indicated use Paracetamol 500 – 1000 mg.
Migraine-specific abortive medications usually are necessary for
moderate to severe migraine headaches. The abortive medica-
tions for moderate or severe migraine headaches are different
than OTC analgesics. Instead of relieving pain, they abort
headaches by counteracting the cause of the headache, dilation
of the temporal arteries. In fact, they cause narrowing of the ar-
teries. Examples of migraine-specific abortive medications are
the triptans and ergot preparations.
Traditionally, triptans were prescribed for moderate or severe
migraines after OTC analgesics and other simple measures
failed. Newer studies suggest that triptans can be used as the
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first treatment for patients with migraines that are causing dis-
ability. (Significant disability is defined as more than 10 days of
at least 50% disability during a three-month period.). Triptans
should be used early after the migraine begins, before the onset
of pain or when the pain is mild. Using a triptan early in an at-
tack increases its effectiveness, reduces side effects, and decreases
the chance of recurrence of another headache during the fol-
lowing 24 hours. Used early, triptans can be expected to abort
more than 80% of migraine headaches within two hours. Er-
gots, like triptans, are medications that abort migraine
headaches. These may be combined with caffeine and/or other
pain relief medications in combination products. Examples of
ergots include ergotamine preparations (Ergomar, Wigraine,
and Cafergot) and dihydroergotamine preparations (Migranal,
DHE-45). There is also a combined medication for specific
treatment of migraine (Nomigren) which consists of 5 ingridi-
ents including ergotamine.
The presented algorithm of migraine  diagnosis and treatment
is based on European recommendations for migraine treatment
and is designed to assist physicians in making appropriate
choices in the management and treatment of migraine patients.
